Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer

Condition:   Breast Cancer Interventions:   Combination Product: Docetaxel / Capecitabine;   Combination Product: Capecitabine / Vinorelbine;   Combination Product: Paclitaxel / Gemcitabine;   Drug: Ribociclib;   Drug: Letrozole OR Anastrozole;   Drug: Goserelin Sponsor:   Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials